Cost-Effective Production of L-DOPA by Tyrosinase-Immobilized Polyhydroxyalkanoate Nanogranules in Engineered Halomonas bluephagenesis TD01

3,4-dihydroxyphenyl-L-alanine (L-DOPA) is a preferred drug for Parkinson’s disease, with an increasing demand worldwide that mainly relies on costly and environmentally problematic chemical synthesis. Yet, biological L-DOPA production is unfeasible at the industrial scale due to its low L-DOPA yield...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jiping, Ran, Ganqiao, Xu, Mengmeng, Lu, Xiaoyun, Tan, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270294/
https://www.ncbi.nlm.nih.gov/pubmed/34206459
http://dx.doi.org/10.3390/molecules26133778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270294/
https://www.ncbi.nlm.nih.gov/pubmed/34206459
http://dx.doi.org/10.3390/molecules26133778

Ejemplares similares